Blume-Jensen Peter (CIK 1950499) reported 20 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-20). Recent activity: Buy ACRV (180,095 shares), Buy ACRV (72,706 shares), Sell ACRV (1,253 shares), Sell ACRV (490 shares), Sell ACRV (14,265 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-20 | Acrivon Therapeutics, Inc. (ACRV) | President and CEO | Buy | 180,095 | $0 |
| 2026-05-20 | Acrivon Therapeutics, Inc. (ACRV) | President and CEO | Buy | 72,706 | $0 |
| 2026-05-18 | Acrivon Therapeutics, Inc. (ACRV) | President and CEO | Sell | 1,253 | $2,406 |
| 2026-05-18 | Acrivon Therapeutics, Inc. (ACRV) | President and CEO | Sell | 490 | $941 |
| 2026-02-24 | Acrivon Therapeutics, Inc. (ACRV) | President and CEO | Sell | 14,265 | $21,825 |
| 2026-02-18 | Acrivon Therapeutics, Inc. (ACRV) | President and CEO | Sell | 1,302 | $2,122 |
| 2026-02-18 | Acrivon Therapeutics, Inc. (ACRV) | President and CEO | Sell | 579 | $944 |
| 2026-01-16 | Acrivon Therapeutics, Inc. (ACRV) | President and CEO | Buy | 49,000 | $82,320 |
| 2025-11-25 | Acrivon Therapeutics, Inc. (ACRV) | President and CEO | Sell | 19,904 | $45,779 |
| 2025-11-18 | Acrivon Therapeutics, Inc. (ACRV) | President and CEO | Sell | 59,765 | $133,874 |
| 2025-11-18 | Acrivon Therapeutics, Inc. (ACRV) | President and CEO | Sell | 490 | $1,098 |
| 2025-08-25 | Acrivon Therapeutics, Inc. (ACRV) | President and CEO | Sell | 19,905 | $26,275 |
| 2025-08-18 | Acrivon Therapeutics, Inc. (ACRV) | President and CEO | Sell | 59,766 | $83,075 |
| 2025-08-18 | Acrivon Therapeutics, Inc. (ACRV) | President and CEO | Sell | 490 | $681 |
| 2025-05-23 | Acrivon Therapeutics, Inc. (ACRV) | President and CEO | Sell | 19,904 | $22,890 |
| 2025-05-16 | Acrivon Therapeutics, Inc. (ACRV) | President and CEO | Sell | 59,766 | $68,133 |
| 2025-05-16 | Acrivon Therapeutics, Inc. (ACRV) | President and CEO | Sell | 491 | $560 |
| 2025-02-25 | Acrivon Therapeutics, Inc. (ACRV) | President and CEO | Sell | 19,904 | $110,268 |
| 2025-02-19 | Acrivon Therapeutics, Inc. (ACRV) | President and CEO | Sell | 37,152 | $201,364 |
| 2025-02-19 | Acrivon Therapeutics, Inc. (ACRV) | President and CEO | Sell | 579 | $3,138 |
Source: SEC Form 4 filings · as of 2026-05-20